Integrated evaluation of targeted and non‐targeted therapies in a network meta‐analysis
Individualized therapies for patients with biomarkers are moving more and more into the focus of research interest when developing new treatments. Hereby, the term individualized (or targeted) therapy denotes a treatment specifically developed for biomarker‐positive patients.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2020
|
| In: |
Biometrical journal
Year: 2020, Volume: 62, Issue: 3, Pages: 777-789 |
| ISSN: | 1521-4036 |
| DOI: | 10.1002/bimj.201800322 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/bimj.201800322 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/bimj.201800322 
|
| Author Notes: | Tanja Proctor, Katrin Jensen, Meinhard Kieser |
| Summary: | Individualized therapies for patients with biomarkers are moving more and more into the focus of research interest when developing new treatments. Hereby, the term individualized (or targeted) therapy denotes a treatment specifically developed for biomarker‐positive patients. |
|---|---|
| Item Description: | First published: 23 September 2019 Correction added on 28 October 2020, after first online publication: Projekt Deal funding statement has been added Gesehen am 26.01.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1521-4036 |
| DOI: | 10.1002/bimj.201800322 |